6.2 GPCRs and the cAMP Signaling Pathway

Core Explanation

GPCRs (G-protein-coupled receptors) share a conserved architecture: seven transmembrane α-helices (7TM), an extracellular N-terminus, and an intracellular C-terminus. Ligand binding to the extracellular face or within the transmembrane bundle induces a conformational change that propagates to the intracellular loops, creating a high-affinity binding surface for a heterotrimeric G protein.

Heterotrimeric G proteins are molecular switches composed of three subunits:

• Gα: Binds guanine nucleotides (GDP in the resting state) and possesses intrinsic GTPase activity. The Gα subunit defines the G protein's downstream identity: Gαs (stimulates adenylyl cyclase), Gαi (inhibits adenylyl cyclase), Gαq (activates phospholipase C-β), and Gα12/13 (regulates RhoGEFs).
• Gβγ: An obligate dimer that, upon dissociation from Gα-GTP, can independently signal to effectors including ion channels (GIRK channels), PI3Kγ, and PLCβ.

The activation cycle:

1. Resting state: Gα-GDP tightly associates with Gβγ. The heterotrimer is anchored to the inner leaflet of the plasma membrane via lipid modifications (myristoylation or palmitoylation of Gα; prenylation of Gγ).
2. Ligand binding: Agonist-bound GPCR acts as a guanine nucleotide exchange factor (GEF) for Gα. The receptor's intracellular loops engage the Gα subunit, prying open the nucleotide-binding pocket and promoting GDP release.
3. GTP binding: Because cytosolic GTP (~1 mM) far exceeds GDP (~10 µM), GTP rapidly occupies the empty pocket. GTP binding induces a conformational change in three "switch" regions of Gα, reducing its affinity for Gβγ.
4. Subunit dissociation: Gα-GTP and Gβγ separate, each now free to interact with downstream effectors.
5. Effector activation: Gαs-GTP binds and activates adenylyl cyclase (AC), a 12-transmembrane-spanning enzyme that converts ATP → cAMP + PPi.
6. Signal propagation: cAMP binds the regulatory subunits of protein kinase A (PKA), releasing the catalytic subunits. Free catalytic subunits phosphorylate serine/threonine residues on target proteins, including metabolic enzymes (glycogen phosphorylase kinase), transcription factors (CREB), and ion channels.
7. Termination: Gα's intrinsic GTPase activity hydrolyzes GTP → GDP + Pi (rate: ~2–5 min⁻¹ for Gαs). Gα-GDP reassociates with Gβγ, reforming the inactive heterotrimer. cAMP is hydrolyzed to 5'-AMP by cyclic nucleotide phosphodiesterases (PDEs) .

Molecular Components

Step-by-Step Mechanism: Epinephrine → Glycogenolysis in Liver

1. Epinephrine binds β₂-adrenergic receptor (a GPCR) on hepatocyte surface.
2. Activated receptor catalyzes GDP → GTP exchange on Gαs.
3. Gαs-GTP activates adenylyl cyclase.
4. AC produces cAMP; intracellular [cAMP] rises from ~10⁻⁷ M to ~10⁻⁵ M.
5. cAMP activates PKA.
6. PKA phosphorylates phosphorylase kinase, which phosphorylates glycogen phosphorylase.
7. Glycogen phosphorylase cleaves glycogen → glucose-1-phosphate → glucose-6-phosphate → free glucose exported to blood.
8. Amplification: One epinephrine molecule → ~100 Gαs activated → each AC produces many cAMP → each PKA phosphorylates many targets → enzymatic glycogenolysis. Total amplification: ~10⁸-fold.

Regulation

• Gαi-mediated inhibition: Gαi-coupled receptors (e.g., α₂-adrenergic, D₂-dopamine, μ-opioid) inhibit certain AC isoforms, opposing Gαs signaling. This enables bidirectional control — a cell can integrate stimulatory and inhibitory inputs converging on cAMP.
• PDE activity: PDE isoforms (PDE1–PDE11) differ in substrate specificity (cAMP-specific, cGMP-specific, dual), regulation (Ca²⁺/calmodulin, phosphorylation, cGMP binding), and tissue distribution. PDE4 is a major cAMP-hydrolyzing isoform in inflammatory cells (targeted by roflumilast in COPD).
• Receptor desensitization: GRKs (G-protein receptor kinases) phosphorylate agonist-occupied GPCRs, recruiting β-arrestin, which sterically blocks G protein coupling and targets the receptor for clathrin-mediated endocytosis.
• RGS proteins: These GTPase-accelerating proteins (GAPs) bind Gα-GTP and stabilize the transition state for GTP hydrolysis, dramatically accelerating signal termination. The RGS protein family contains >30 members with distinct Gα specificities.
• PKA feedback: PKA can phosphorylate the β-adrenergic receptor itself (heterologous desensitization) and certain AC isoforms, providing negative feedback.

Energy

• Signal synthesis: Each cAMP molecule costs two high-energy phosphate bonds (ATP → cAMP + PPi; PPi → 2 Pi by pyrophosphatase).
• Kinase cascade: Each phosphorylation event consumes one ATP.
• GTP cycle: One γ-phosphate of GTP is hydrolyzed per activation cycle.
• The cost of amplification: The ~10⁸-fold amplification of the epinephrine → glucose response is thermodynamically expensive but evolutionarily justified by the survival advantage of rapid glucose mobilization during fight-or-flight.

Experimental Evidence

• Sutherland & Rall (1958): Discovered cAMP as the heat-stable factor produced by epinephrine-treated liver membranes that activated glycogen phosphorylase.
• Gilman & Rodbell (Nobel 1994): Used S49 lymphoma cell mutants lacking functional Gαs to prove G proteins are essential for hormonal activation of adenylyl cyclase. Reconstitution with purified Gαs restored epinephrine-stimulated cAMP production.
• Lefkowitz & Kobilka (Nobel 2012): Cloned the β₂-adrenergic receptor — the first GPCR — and solved its crystal structure in active and inactive conformations, revealing the molecular basis of GPCR activation.
• Fluorescence resonance energy transfer (FRET): Live-cell FRET biosensors (e.g., Epac-based cAMP sensors) demonstrated that cAMP signals are spatially and temporally compartmentalized, not uniformly distributed.

Disease / Clinical Relevance

• Cholera toxin: Vibrio cholerae toxin catalyzes ADP-ribosylation of Gαs at Arg-201, inhibiting its intrinsic GTPase activity. Gαs remains locked in the GTP-bound (active) state, producing persistent, unregulated cAMP elevation in intestinal epithelial cells. This drives massive Cl⁻ and water secretion into the gut lumen → severe watery diarrhea (up to 20 L/day, "rice-water stool").
• Pertussis toxin: Bordetella pertussis toxin ADP-ribosylates Gαi at a C-terminal cysteine, preventing receptor–G protein coupling. Gαi cannot be activated, removing inhibitory tone on adenylyl cyclase. In airway epithelial cells, elevated cAMP contributes to the paroxysmal coughing characteristic of whooping cough.
• McCune-Albright syndrome: Somatic activating mutations in GNAS (encoding Gαs) cause constitutive cAMP signaling, leading to fibrous dysplasia, café-au-lait spots, and precocious puberty (when occurring in gonadal tissue).
• Pseudohypoparathyroidism type Ia: Loss-of-function GNAS mutations cause resistance to PTH (which signals through Gαs), producing hypocalcemia and hyperphosphatemia despite elevated PTH levels, plus characteristic skeletal features (Albright hereditary osteodystrophy).
• Pharmacology: β-blockers (propranolol, metoprolol) are competitive antagonists at β-adrenergic receptors. β-agonists (albuterol) activate β₂ receptors to relax bronchial smooth muscle in asthma, acting through Gαs → cAMP → PKA → smooth muscle relaxation.

High-Yield Summary

• GPCRs are 7TM receptors that catalyze GDP/GTP exchange on heterotrimeric G proteins.
• Gαs-GTP activates adenylyl cyclase → ATP → cAMP; cAMP activates PKA; PKA phosphorylates downstream targets including CREB.
• Gαi-GTP inhibits adenylyl cyclase (opposes Gαs). Gβγ also signals independently.
• Signal termination: intrinsic GTPase activity of Gα, accelerated by RGS GAPs; PDE hydrolysis of cAMP; receptor desensitization via GRK/β-arrestin.
• Cholera toxin: irreversible Gαs activation (↓ GTPase). Pertussis toxin: uncouples Gαi from receptor.

Practice Questions

Q1: Explain how a single epinephrine molecule binding one β-adrenergic receptor can trigger the release of ~10⁸ glucose molecules. Identify every step of amplification.

A1: Amplification occurs at four sequential stages:

1. Receptor–G protein: One agonist-bound GPCR can activate multiple Gαs proteins catalytically (it acts as a GEF, not a stoichiometric partner). A single receptor can activate ~100 Gα molecules.
2. cAMP synthesis: One Gαs-GTP activates one adenylyl cyclase, but each AC enzyme produces many cAMP molecules before Gα hydrolyzes GTP (~4 min⁻¹ GTPase rate). Each AC can generate hundreds of cAMP.
3. PKA activation: cAMP activates PKA, and each active PKA catalytic subunit phosphorylates many target enzymes (phosphorylase kinase).
4. Enzymatic cascade: Each phosphorylase kinase molecule activates many glycogen phosphorylase enzymes, and each glycogen phosphorylase cleaves many glucose-1-phosphate molecules from glycogen. Combined: 1 × 100 × ~100 × ~100 × ~1000 ≈ 10⁸.

Q2: How would a mutation that increases the intrinsic GTPase rate of Gαs affect cAMP signaling?

A2: Increased GTPase activity would shorten the duration of Gαs-GTP (the active species), reducing the time adenylyl cyclase is stimulated. This would lower peak cAMP levels and abbreviate the signaling response. The cell would be less responsive to agonist stimulation — effectively a loss-of-function phenotype. This explains why RGS proteins, which are physiological GAPs, dampen signaling, and why cholera toxin (which blocks GTPase) causes pathological hyperactivation.

Q3: Compare and contrast the molecular mechanisms of cholera toxin and pertussis toxin. Why do both toxins increase cAMP, yet one produces intestinal hypersecretion while the other causes respiratory pathology?

A3: Cholera toxin ADP-ribosylates Gαs at Arg-201, inhibiting its GTPase activity → constitutive Gαs-GTP → persistent AC activation → massive cAMP elevation. Pertussis toxin ADP-ribosylates Gαi at a C-terminal cysteine, uncoupling it from inhibitory receptors → Gαi cannot be activated by its cognate GPCRs → loss of tonic inhibition of AC → moderately elevated cAMP. Both raise cAMP, but tissue tropism matters: cholera toxin targets intestinal epithelium (Gαs-driven CFTR activation → massive Cl⁻/water secretion → "rice-water stool"); pertussis toxin targets respiratory epithelium (Gαi uncoupling → disrupted signaling, inflammatory response, paroxysmal cough). The distinct clinical presentations reflect the anatomical distribution and signaling logic of the affected G protein isoforms.

Common Misconceptions

• ❌ "The G protein stays permanently dissociated after activation." → Gα hydrolyzes GTP (intrinsic GTPase, accelerated by RGS proteins), then reassociates with Gβγ, restoring the resting state.
• ❌ "All GPCR ligands bind the N-terminus." → Ligand binding sites vary dramatically. Small ligands (epinephrine, dopamine) bind within the transmembrane helical bundle. Large peptide ligands (glucagon, PTH) and glycoprotein hormones (TSH, LH) bind the extended N-terminal domain. Protease-activated receptors (PARs) carry their own tethered ligand exposed by proteolytic cleavage.
• ❌ "Cholera toxin and pertussis toxin both increase cAMP by the same mechanism." → Cholera toxin constitutively activates Gαs (by blocking GTPase). Pertussis toxin inactivates Gαi (by uncoupling from receptor), removing inhibitory input — both raise cAMP, but by fundamentally different mechanisms.